Duane S. Pinto, M.D., M.P.H., F.A.C.C., F.S.C.A.I.

Dr. Pinto received his B.A., cum Laude, from Dartmouth College in Hanover, NH and M.D. degree from the Georgetown University, cum Laude and Alpha Omega Alpha. He was an Intern, Resident, Chief Resident, General Cardiology Fellow and Interventional Cardiology Fellow at Harvard Medical School and Beth Israel Hospital, Boston, MA. Dr. Pinto is an Associate Professor of Medicine at Harvard Medical School and serves as the Director of the Cardiac Intensive Care Unit, and Chief of the Interventional Section. He has advanced training in biostatistics as part of the clinical effectiveness program at the Harvard School of Public Health.

He was the Director of the General Cardiology Fellowship Program at Beth Israel Deaconess Medical Center for 10 years. He has been awarded cardiology fellow teaching and mentorship awards from Harvard Medical School. Currently, he is the Governor of the Massachusetts Chapter of the American College of Cardiology.

He serves on the scientific sessions planning committee for the American College of Cardiology, American Heart Association, and Society for Cardiac Angiography and Intervention. As an acknowledged technical operator, he performs complex PCI, CTO and TAVR and has been invited to Egypt, China and Vietnam to do complex coronary and peripheral cases. He is a US proctor for the Evolut-R Transcatheter Aortic Valve.

Dr. Pinto was the editor of the Controversies in Cardiology section for Circulation. He is a manuscript reviewer for the New England Journal, Circulation and the Journal of the American College of Cardiology. He has published over 75 articles in journals such as The New England Journal of Medicine, Circulation, Journal of the American College of Cardiology and JAMA. Dr. Pinto has research interests in a wide variety of topics including acute myocardial infarction studies, unstable angina studies, interventional trials, peripheral interventional trials specializing in clinical outcomes, comparative effectiveness and cost-effectiveness studies. He is currently an investigator in numerous transcatheter and coronary stent trials.

  • Pinto DS, Tu TM. Ventricular Septal Rupture after Myocardial Infarction. New England Journal of Medicine 2002; 347:1334.
  • Gibson CM, Pinto DS, Murphy SA, Morrow DA, Wiviott SD, Giugliano RP, Cannon CP, Antman EM, Braunwald E. Association of Creatinine and Creatinine Clearance on Presentation in Acute Myocardial Infarction with Subsequent Mortality. Journal of the American College of Cardiology. 2003;42:1535–43
  • Jeremias A, Sylvia B, Bridges J, Bigelow B, Ho KK, Pinto DS, Cohen DJ, Cutlip DE, Carrozza JP Jr, Subacute Stent Thrombosis After Successful Placement of Sirolimus-Eluting Coronary Stents: Real World Experience. Circulation. 2004;109:1930-1932.
  • Pinto DS, Skolnick AH, Kirtane AJ, Murphy SA, Barron HV, Giugliano RP, Cannon, CP, Gibson CM. U-Shaped Relationship of Blood Glucose with Adverse Outcomes Among Patients with ST-Elevation Myocardial Infarction. J Am Coll Cardiol 2005; 46: 178-183.
  • Pinto DS, Blair BM, Schwartzstein RM, Smith CC. A Sailor’s Heartbreak. New England Journal of Medicine. 2005; 353: 934-939.
  • Pinto DS, Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaugnessy C, Mann JT, Mehran R, Na Y, Turco M, Caputo R, Popma JJ, Cutlip DE, Russell ME, Cohen DJ. Impact of Routine Angiographic Follow-up on the Clinical Benefits of Paclitaxel Eluting Stents: Results from the TAXUS-IV Trial. Journal of the American College of Cardiology. 2006; 48:32-36.
  • Pinto DS, Kirtane AJ, Nallamothu BK, Murphy SA, Cohen DJ, Laham RJ, Cutlip DE, Bates ER, Frederick PD, Miller DP, Carrozza JP, Antman EM, Cannon CP, Gibson CM. Hospital Delays in Reperfusion for ST-Elevation Myocardial Infarction: Implications When Selecting a Reperfusion Strategy. Circulation. 2006; 114:2019-2025.